Epigenetics and therapeutic targets in gastrointestinal malignancies.
Sign Up to like & getrecommendations! Published in 2021 at "Drug discovery today"
DOI: 10.1016/j.drudis.2021.04.013
Abstract: Gastrointestinal (GI) malignancies account for substantial mortality and morbidity worldwide. They are generally promoted by dysregulated signal transduction and epigenetic pathways, which are controlled by specific enzymes. Recent studies demonstrated that histone deacetylases (HDACs) together… read more here.
Keywords: epigenetics therapeutic; gastrointestinal malignancies; targets gastrointestinal; therapeutic targets ... See more keywords